Form 144/A PALVELLA THERAPEUTICS, Filed by: Goin Kathleen
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA grants rolling review for Palvella's rapamycin NDA for rare condition
- SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
- Statt Launches Advisory Board of Government Relations, Public Affairs, and Technology Leaders to Shape the Future of AI-Powered Public Policy Work
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
